Lupus Research Alliance Launches Two Major Initiatives to Increase Participation of Underrepresented Minorities in Lupus Clinical Trials and Research

NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and clinical affiliate Lupus Therapeutics (LT) announced two major initiatives improving  representation of minorities in clinical trials and  the scientific research profession: Project CHANGE by LT and the Diversity in Lupus Research Program. The LRA has been addressing these disparities for many years and now proudly launches this multi-pronged plan for equity among people with lupus and professionals in this field.

The full press release is available on the Lupus Therapeutics website.

Read full Press Release

Recent Press Releases